186 results on '"Walther, Axel"'
Search Results
2. Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial
3. Challenges in Using Recommended Quality of Life Measures to Assess Fluctuating Health: A Think-Aloud Study to Understand How Recall and Timing of Assessment Influence Patient Responses
4. Objective responses to first-line neoadjuvant carboplatin–paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial
5. Die Motivation von Arbeitnehmervertreterinnen und -vertretern zur Übernahme eines Aufsichtsratsmandats : Ein qualitativer Ansatz
6. #159 ICON8B: GCIG phase III randomised trial comparing weekly dose-dense chemotherapy + bevacizumab to three-weekly chemotherapy+ bevacizumab in first-line high-risk stage III-IV epithelial ovarian cancer treatment: primary progression-free survival analysis
7. Got a plan in the pipeline? Nominating committee’s information processing in executive successions
8. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33
9. The role of behaviorally integrated nominating committees in non-executive director selection processes
10. Non-executive director’s motivation to continue serving on boards: a self-determination theory perspective
11. Copy number signatures and mutational processes in ovarian carcinoma
12. Data from Chromosomal Instability Confers Intrinsic Multidrug Resistance
13. Supplementary Table 1 from Chromosomal Instability Confers Intrinsic Multidrug Resistance
14. Supplementary Figures 4-6 from Chromosomal Instability Confers Intrinsic Multidrug Resistance
15. Supplementary Figure Legends 1-6 from Chromosomal Instability Confers Intrinsic Multidrug Resistance
16. Supplementary Figures 1-3 from Chromosomal Instability Confers Intrinsic Multidrug Resistance
17. Research participation registers can increase opportunities for patients and the public to participate in health services research
18. Effects of polyacrylonitrile fibres and high content of RAP on mechanical properties of asphalt mixtures in binder and base layers.
19. Effects of polyacrylonitrile fibres and high content of RAP on mechanical properties of asphalt mixtures in binder and base layers
20. ENGOT-en11/GOG-3053/KEYNOTE-B21: A phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed high-risk endometrial cancer (570)
21. Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis
22. British Gynaecological Cancer Society (BGCS) uterine cancer guidelines: Recommendations for practice
23. Integration of Materials Science-based Performance Models into PMS
24. Comprehensive assessment of variation at the transforming growth factor β type 1 receptor locus and colorectal cancer predisposition
25. Challenges in Using Recommended Quality of Life Measures to Assess Fluctuating Health: A Think-Aloud Study to Understand How Recall and Timing of Assessment Influence Patient Responses
26. ENGOT-en11/GOG-3053/KEYNOTE-B21: Phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with/without radiotherapy in patients with newly diagnosed high-risk endometrial cancer.
27. ENGOT-en11/GOG-3053/KEYNOTE-B21: Phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with/without radiotherapy in patients with newly diagnosed high-risk endometrial cancer
28. Comprehensive assessment of variation at the transforming growth factor [beta] type 1 receptor locus and colorectal cancer predisposition
29. Low penetrance breast cancer predisposition SNPs are site specific
30. COPY-NUMBER SIGNATURES AND MUTATIONAL PROCESSES IN HIGH GRADE SEROUS OVARIAN CARCINOMA
31. TMT Involvement in Family Firm’s Growth-Related Strategic Decision-Making: A Dynamic Capability Perspective
32. Therapeutic options following second-line platinum-based chemotherapy in patients with recurrent ovarian cancer: Comparison of active surveillance and maintenance treatment
33. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals
34. Chapter 3 Cardiovascular
35. Chapter 7 Endocrine and metabolic
36. Chapter 10 Oncology and palliative care
37. Chapter 9 Musculoskeletal
38. Chapter 4 Respiratory
39. Chapter 6 Gastrointestinal
40. Perioperative Medicine
41. Chapter 12 Useful information
42. Chapter 1 Investigations
43. Chapter 2 Perioperative care
44. Chapter 8 Neurology
45. Chapter 5 Renal and urological
46. Chapter 11 Procedures
47. Review of gynaecological malignant melanomas
48. Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer
49. Abstract AP09: COPY-NUMBER SIGNATURES AND MUTATIONAL PROCESSES IN HIGH GRADE SEROUS OVARIAN CARCINOMA
50. Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.